Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat

Behavioural Brain Research

Volumn 106, Issue 1-2, 1999, Pages 143-150

  Hauber, Wolfgang ^a   Lutz, Sylke ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Catalepsy; Caudate putamen; SCH23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; SULPIRIDE; DOPAMINE RECEPTOR BLOCKING AGENT;

AKINESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC TRANSMISSION; GLOBUS PALLIDUS; MALE; MOTOR CONTROL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; AUTORADIOGRAPHY; DRUG ANTAGONISM; DRUG EFFECT; DYSKINESIA; MICROINJECTION; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT; STEREOTAXIC SURGERY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORADIOGRAPHY; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; GLOBUS PALLIDUS; MALE; MICROINJECTIONS; MOVEMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STEREOTAXIC TECHNIQUES; SULPIRIDE;

EID: 0032586024     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00102-3     Document Type: Article

References (70)

1. Ahlenius S, Briem S, Hillegaart V, Magnusson O. Diffusion and absorption of (-)sulpiride and raclopride after intracerebral administration in the rat. Biochem Pharm 1990;39:2066-9.
2. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-75.
3. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-81.
4. Amalric M, Koob GF. Dorsal pallidum as a functional motor output of the corpus striatum. Brain Res 1989;483:389-94.
5. Apicella P, Legallet E, Nieoullon A, Trouche E. Neglect of contralateral visual stimuli in monkeys with unilateral striatal dopamine depletion. Behav Brain Res 1991;46:187-95.
6. Apicella P, Trouche E, Nieoullon A, Legallet E, Dusticier N. Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesions of the nigrostriatal dopaminergic system in monkeys. Neuroscience 1990;38:655-66.
7. 125I]DOI) binding to 5-HT2 and 5-HTlc receptors in rat brain. J Pharmacol Exp Ther 1990;255:843-57.
8. Avdelidis D, Spyraki C. Dopamine-dependent behaviours in rats with bilateral ibotenic acid-induced lesions of the globus pallidus. Brain Res Bull 1986;16:25-32.
9. Bottger G, Schmidt J. Effects of striatum stimulation and micro-iontophoretically applied dopamine and acetylcholine on the neuronal activity of the globus pallidus. Acta Biol Med Ger 1980;39:123-31.
10. Chesselet M-F, Delfs JM. Basal ganglia and movement disorders: an update. Trends Neurosci 1996;19:417-22.
11. Clark D, White FJ. D1 dopamine receptor - the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse 1987;1:347.
12. Colpaert FC. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology 1987;26:1431.
13. Costall B, De Souza CX, Naylor RJ. Topographical analysis of the actions of 2-(N,N-dipropyl)amino-5,6-dihydroxytetralin to cause biting behaviour and locomotor hyperactivity from the striatum of the guinea-pig. Neuropharmacology 1980;19:623-31.
14. Costall B, Naylor RJ. Neuroleptic and non-neuroleptic catalepsy. Arzneim-Forsch (Drug Res) 1973;23:674-83.
15. Costall B, Naylor RJ, Olley JE. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anti-cholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology 1972;11:645-63.
16. Costall B, Olley JE. Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra. Neuropharmacology 1971;10:581-94.
17. Cromwell HC, Berridge KC. Mapping of globus pallidus and ventral pallidum lesions that produce hyperkinetic treading. Brain Res 1994;668:16-29.
18. Elliott PJ, Walsh DM, Close SP, Higgins GA, Hayes AG. Behavioural effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmacology 1990;29:949-56.
19. Ernst AM, Smelik PG. Site of action of dopamine and apomorphine on compulse gnawing behaviour in rats. Experientia 1968;22:837-8.
20. Fallon JH, Moore RY. Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 1978;180:545-50.
21. Féger J. Updating the functional model of the basal ganglia. Trends Neurosci 1997;20:152-3.
22. Fletcher GH, Starr MS. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat. Eur J Pharmacol 1987;138:407-11.
23. Floran B, Aceves J, Sierra A, Martinez-Fong D. Activation of Dl dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 1990;116:136-40.
24. Floran B, Floran L, Sierra A, Aceves J. D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 1997;237:1-4.
25. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchack PA, Collins F, Hoffer BJ, Gerhardt GA. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996;380:252-5.
26. Gerfen CR, Wilson CJ. In: Swanson LW, Björklund A, Hökfelt T, editors. The Basal Ganglia. Handbook of Chemical Neuroanatomy: Integrated Systems of the CNS, Part III, vol. 12. Amsterdam: Elsevier, 1996:371-468.
27. Hauber W. Blockade of subthalamic dopamine D1 receptors elicits akinesia in rats. Neuroreport 1998;9:4115-8.
28. Hauber W, Lutz S. Blockade of dopamine D2, but not of D1 receptors in the rat globus pallidus induced Fos-like immunoreactivity in the caudate-putamen, substantia nigra and entopeduncular nucleus. Neurosci. Lett. 1999:in press.
29. Hauber W, Lutz S, Münkle M. The effects of globus pallidus-lesions on dopamine-dependent motor behaviour in rats. Neuroscience 1998;86:147-57.
30. Hauber W, Munkle M. Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors. Neurosci Lett 1995;196:205-8.
31. Herkenham M, Lynn AB, de Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 1991;547:267-74.
32. Hicks PB. The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci 1990;47:1609-15.
33. Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 1998;51:S2-9.
34. Kelland MD, Soltis RP, Anderson LA, Bergstrom DA, Walters JR. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia. Synapse 1995;20:338-50.
35. Konitsiotis S, Kafetzopoulos E, Anastasopoulos D, Blanchet PJ. Opposite rotation induced by dopamine agonists in rats with unilateral lesions of the globus pallidus or substantia nigra. Behav Brain Res 1998;92:77-83.
36. Koshikawa N, Koshikawa F, Tomiyama K, Kikuchi de Beltran K, Kamimura F, Kobayashi M. Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats. Eur J Pharmacol 1990;182:375-80.
37. Koshikawa N, Tomiyama K, Omiya K, Kikuchi de Beltran K, Kobayashi M. Dopamine D1 but not D2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats. Eur J Pharmacol 1990;178:189-94.
38. Limon ID, Martinez-Fong M, Roslaes A, Nunez A, Aceves J. Dopamine inhibits GABA and stimulates glutamate release in the rat globus pallidus. Soc Neurosci Abstr 1997;23:747.
39. Lindvall O, Björklund A. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res 1979;172:169-73.
40. McQuade RD, Ford D, Duffy RA, Chipkin RE, Ioro IC, Barnett A. Serotonergic component of SCH23390: in vitro and in vivo binding analysis. Life Sci 1988;43:1861-9.
41. Miwa H, Fuwa T, Yokochi M, Nishi K, Mizuno Y. Injection of a GABA antagonist into the mesopontine reticular formation abolishes haloperidol-induced catalepsy in rats. Neuroreport 1996;7:2475-8.
42. Moriizumi T, Hattori T. Separate neuronal populations of the rat globus pallidus projecting to the subthalamic nucleus, auditory cortex and pedunculopontine tegmental area. Neuroscience 1992;46:701-10.
43. Nakanishi H, Hori N, Kastuda N. Neostriatal evoked inhibition and effects of dopamine on globus pallidal neurons in rat slice preparations. Brain Res 1985;358:282-6.
44. Nambu A, Llinas R. Morphology of globus pallidus neurons: its correlation with electrophysiology in guinea pig brain slices. J Comp Neurol 1997;377:85-94.
45. Napier TC. Transmitter actions and interactions on pallidal neuronal function. In: Limbic Motor Circuits and Neuropsychiatry. Boca Raton, FL: CRC Press, 1993:125-53.
46. Napier TC, Simson PE, Givens BS. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. J Pharmacol Exp Ther 1991;258:249-62.
47. Neal-Beliveau BS, Yoyce JN, Lucki I. Serotonergic involvement in haloperidol-catalepsy. J Pharmacol Exp Ther 1993;265:207-17.
48. Ögren SO, Fuxe K. Dl- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways. Neurosci Lett 1988;85:333-8.
49. Olianas MC, DeMontis GM, Concu A, Tagliamonte A, Di Chiara G. Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones. Eur J Pharmacol 1978;49:223-32.
50. Ossowska K, Karcz M, Wardas J, Wolfarth S. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy. Eur J Pharmacol 1990;182:327-34.
51. Ossowska K, Smialowska M, Wolfarth S. A biphasic influence of globus pallidus lesions: spontaneous catalepsy followed by anticataleptic effect. Pharmacol Biochem Behav 1983;19:169-76.
52. Ossowska K, Wedzony K, Wolfarth S. The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity. Pharmacol Biochem Behav 1984;21:825-31.
53. Ozer H, Ekinci AC, Starr MS. Dopamine D-1- and D-2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Res 1997;777:51-9.
54. Parent A, Cicchetti F. The current model of basal ganglia organization under scrutiny. Mov Disord 1998;13:199-202.
55. Parent A, Hazrati L-N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 1995;20:91-127.
56. Parent A, Hazrati L-N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 1995;20:128-54.
57. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, New York: Academic Press, 1986.
58. Richfield EK, Young AB, Penney JB. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J Comp Neurol 1987;262:446-63.
59. Robertson GS, Robertson HA. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 1989;9:3326.
60. Scheel-Krüger J, Arnt J, Magelund G, Olianas M, Przewlocka B, Christensen AV. Behavioural functions of GABA in basal ganglia and limbic systems. Brain Res Bull 1980;5:261-7.
61. Schultz W, Romo R, Scarnati E, Sundström E, Jonsson G, Studer A. Saccadic reaction times, eye-arm coordination and spontaneous eye movements in normal and MPTP-treated monkeys. Exp Brain Res 1989;78:253-67.
62. Schultz W, Studer A, Jonsson G, Sundström E, Mefford I. Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. Neurosci Lett 1985;59:225-32.
63. Soltis RP, Anderson LA, Walters JR, Kelland MD. A role for non-NMDA excitatory amino acid receptors in regulating the basal activity of rat globus pallidus neurons and their activation by the subthalamic nucleus. Brain Res 1994;666:21-30.
64. 3H](-)sulpiride binding in the rat striatum, cortex and anterior pituitary: an improved assay. Pharmacol Res Commun 1987;19:777-91.
65. Trabucci M, Longoni R, Fresia P, Spano PF. Sulpiride: a study on the effects of dopamine receptors in rat neostriatum and limbic forebrain. Life Sci 1976;17:1551-6.
66. Wadenberg M-L. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev 1996;20:325-39.
67. Wadenberg ML. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH23390 in the rat. J Neural Transm (Gen Sect) 1992;89:49-59.
68. Wardas J, Pietraszek M, Ossowska K, Wolfarth S. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats. Pol J Pharmacol 1995;47:349-53.
69. Wichmann TDMR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6:751-8.
70. Yung KKL, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 1995;65:709-30.